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Tomás Ortiz1 and Alberto Fernández1,5 
Abstract 
Magnetoencephalography (MEG) allows the real-time recording of neural activity and oscillatory activity in distributed neural networks. We applied a 
non-linear complexity analysis to resting-state neural activity as measured using whole-head MEG. Recordings were obtained from 20 unmeditated 
patients with major depressive disorder and 19 matched healthy controls. Subsequently, after 6 months of pharmacological treatment with the 
antidepressant mirtazapine 30mg/day, patients received a second MEG scan. A measure of the complexity of neural signals, the Lempel-Ziv 
Complexity (LZC), was derived from the MEG time series. We found that depressed patients showed higher pre-treatment complexity values compared 
with controls, and that complexity values decreased after 6 months of effective pharmacological treatment, although this effect was statistically 
significant only in younger patients. The main treatment effect was to recover the tendency observed in controls of a positive correlation between age 
and complexity values. Importantly, the reduction of complexity with treatment correlated with the degree of clinical symptom remission. We suggest 
that LZC, a formal measure of neural activity complexity, is sensitive to the dynamic physiological changes observed in depression and may potentially 
offer an objective marker of depression and its remission after treatment. 
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Introduction 
Major depressive disorder (MDD) affects one out of five 
women and one out of ten men during their lifespan (Stein 
et al., 2006). According to the World Health Organization, 
depression was the third leading contributor to the Global 
Burden of Disease in terms of Disability Adjusted Life Years 
in 2004 (WHO, 2004). Currently, there is no consensus about 
the pathophysiology of depression, and there are no biological 
measures widely used in clinical practice for the diagnosis of 
depression or in order to monitor treatment response. 
Neuroimaging techniques such as functional Magnetic 
Resonance Imaging (fMRI) and Positron Emission 
Tomography (PET) have revealed changes in cerebral blood 
flow and metabolism in several brain areas, but findings are 
complex and often contradictory (Steele et al., 2006). Brain 
regions in which functional disturbances have been observed 
include the orbitofrontal cortex, ventromedial and ventrolat-
eral prefrontal cortex, pregenual and subgenual portions of 
the anterior cingulate cortex, posterior cingulate cortex, para-
hippocampal cortex, superior temporal cortex, ventromedial 
striatum, amygdala, and medial thalamus. Metabolic rates 
in these regions are either positively or negatively correlated 
with the degree of symptomatology in patients assessed with 
instruments such as the Hamilton Rating Scale for Depression 
(HAMD) (Kennedy et al., 2001; Preskorn and Drevets, 
2009). 
Electroencephalography (EEG) and magnetoencephalog-
raphy (MEG) have also been used to investigate neurophys-
iological changes in depression. Compared with fMRI and 
PET they offer the advantage of a much higher temporal res-
olution, allowing the real-time recording of neural activity 
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and oscillatory activity in distributed neural networks. 
Compared with EEG, MEG offers a better spatial resolution 
and is sensitive to a broader frequency spectrum than EEG, 
because the skull acts as a low-pass filter for electric currents, 
but not for magnetic fields (Breier et al., 1999; Ilmoniemi, 
1993; Lounasmaa et al., 1996; Nunez et al., 2001). 
For example, several studies have reported increased alpha 
power over left frontal sites, a finding referred to as the frontal 
alpha asymmetry (Davidson, 2004; Debener et al., 2000; Hughes 
and John, 1999; Knott et al., 2001; Monakhov and Perris, 1980). 
This has been considered a marker of reduced left frontal acti-
vation, associated with negative affective tendencies, given that 
alpha oscillations are thought to reflect a reduced activation. 
However, results from EEG/MEG studies have not pro-
vided consistent results either. Other EEG studies, for example 
Knott et al. (2001), described increased beta activity and mean 
frequency values in depressed patients compared with controls, 
and did not find any significant changes in the alpha 
band (Knott et al., 2001). Similar results, affecting the beta 
but not the alpha band, were found by Pizzagalli et al., 
(2002). Wienbruch et al. studied the brain's slow focal activity 
in depressed patients using MEG and found reduced slow-wave 
(delta and theta band) activity in prefrontal and frontal areas 
when compared with controls (Wienbruch et al., 2003), yet 
Fernández et al. described significantly higher right occipital 
delta activity in depressive patients versus controls 
(Fernandez et al., 2005). 
All of these studies used a conventional approach to the 
analysis of EEG/MEG data, namely frequency-power analysis: 
simply speaking, measuring the amplitude of neural oscilla-
tions within a given predefined frequency band. However, 
while useful in many cases, this approach only measures one 
aspect of the EEG/MEG time series, which contains much rich 
information which is not captured by such an analysis. 
We decided to adopt a complementary approach, complex-
ity analysis, in order to investigate neural activity in major 
depression. The theoretical background to this approach has 
been discussed previously (Glass and Mackey, 1979; Mackey 
and Milton, 1987; Sarbadhikari and Chakrabarty, 2001) with 
reference to the concept of'dynamical disease': essentially, the 
idea that depression is a certain pattern or stable state of brain 
activity which the brain can become fixed into as a result of 
genetic, biological or environmental factors (Belair et al., 1995). 
A non-linear analysis of MEG/EEG time series offers an 
approach to understanding such states. The Lempel-Ziv com-
plexity (LZC) (Lempel and Ziv, 1976) is a complexity measure 
which has been used to analyse EEG and MEG signals in 
patients with Alzheimer's disease (Abasólo et al., 2006; Gomez 
et al., 2006), attention-deficit hyperactivity disorder (ADHD) 
(Fernandez et al., 2009), as well as to measure the depth of anaes-
thesia (Zhang et al., 2001), amongst other conditions. 
The LZC is essentially a measure of the unpredictability, 
complexity or 'randomness' of the neural signal. Aboy et al. 
(2006) investigated the factors which affect this complexity 
estimate and concluded that the main determinant of the 
LZC is the bandwidth of the signal. In other words, the 
more the variability in frequency components, the higher 
the LZC values. Other similar measures of complexity have 
been applied to resting-state neural activity using fMRI, for 
example the Hurst exponent in autism (Lai et al., 2010). 
In this study, we decided to further investigate the rela-
tionship between depression and neural complexity. We 
hypothesized that there would be a pattern of increased 
LZC values in major depression (see Li et al., 2008), especially 
in anterior brain regions. We also expected an interaction of 
diagnosis with age, given the fact that previous studies have 
shown an increased frontal EEG/MEG complexity as a func-
tion of age in healthy controls (Anokhin et al., 1996). Finally, 
we studied the effects of 6 months of antidepressant treatment 
in order to elucidate whether changes seen in currently 
depressed patients represent a 'trait' vulnerability marker or 
a 'state' marker of active depression. 
Methods 
Subjects 
In total, 20 right-handed patients (12 female, eight male) 
referred from the Hospital Central de la Defensa Psychiatry 
unit, Madrid, Spain, who fulfilled the Diagnostic and 
Statistical Manual of Mental Disorders, fourth edition (DSM-
IV) criteria for MDD participated in the study. None of the 
patients had a history of substance abuse, other neurological or 
medical conditions, or Axis I or Axis II psychiatric disorders. 
Clinical interviews and diagnosis were performed by their treat-
ing psychiatrist. 
The mean age of patients with depression was 47.55 ± 12.98 
years. Patients were moderately to severely depressed as 
reflected by the 17-item HAMD scores (Hamilton, 1960), 
(mean: 24.75 ± 5.78). In order to avoid the confounding effects 
of medication in the baseline measures and to allow the effects 
of subsequent treatment to be assessed, all patients completed a 
minimum 3-week medication washout before the first MEG 
recordings. 
Immediately after the first (baseline i.e. pre-treatment) 
MEG scan, patients started antidepressant pharmacotherapy 
with mirtazapine 30 mg once a day. Following 6 months of 
treatment, patients received a second MEG (post-treatment) 
scan. 
Some 19 right-handed healthy control subjects (13 female, 
six male) also participated in the study. None of them had a 
history of MDD, substance abuse, or a neurologic or medical 
disorder. Their HAMD scores were under the normal range 
(mean: 4.26 ± 1.52). Controls were recruited by advertisement 
in the Madrid area and selected after a preliminary phone 
interview. The mean age of controls was 45.89 ±16.48 
years. No statistically significant differences were found 
between patients and controls, in terms of mean (p = 0.728) 
or variance (p = 0.309). Handedness was evaluated using the 
Edinburg Inventory (Oldfield, 1971). 
Before entering the study, all participants provided 
written informed consent. The study was approved by the 
Investigation and Ethics Committee of the Hospital Central 
de la Defensa 'Gómez Ulla'. 
Data collection 
MEGs were acquired with a 148-channel whole-head magne-
tometer (MAGNES 2500 WH®, 4D Neuroimaging, San 
Diego, CA, USA) located in a magnetically shielded room. 
Subjects were awake and in a resting state with their eyes 
closed and under observation control during the recording. 
They were asked to avoid blinking and making movements. 
For each subject, 5min of MEG signal were acquired at a 
sampling frequency of 678.17 Hz using a hardware band-pass 
filter of 0.1-200 Hz. Afterwards, these recordings were down-
sampled by a factor of 4 (169.549 Hz). Artefact-free epochs of 
20 s (3392 time points) were selected. Finally, these epochs 
were filtered between 1.5 and 40 Hz then copied to a computer 
as ASCII (American Standard Code for Information 
Interchange) files for further complexity analyses. 
LZC calculation 
LZC is a non-parametric measure for finite sequences related 
to the number of distinct substrings and the rate of their 
occurrence along the sequence, with larger values correspond-
ing to greater complexity in the data (Lempel and Ziv, 1976). 
In this study, we used the simplest method for pre-
processing data into a form which allows the calculation of 
the LZC: a binary sequence conversion (zeros and ones). By 
comparison with a threshold Td, the original data are 
converted into a 0-1 sequence. We used the median as the 
threshold Td due to its well-known robustness to outliers. 
Essentially, therefore, the MEG time series is converted into 
a string of 1 s and 0 s, with a 1 representing that the signal at 
that point in time is higher than the median while a 0 indicates 
that it is lower than the median signal at that channel. 
The LZC is then calculated by scanning the string from left 
to right and increasing a complexity counter c(w) by one unit 
every time a new subsequence of consecutive characters is 
encountered (Zhang et al., 2001). 
In order to obtain a complexity measure which is indepen-
dent of the sequence length n, c(w) should be normalized. In 
general, b(w) = w/log2(w) is the upper bound of c(w) for a 
binary sequence (Lempel and Ziv, 1976). Thus, c(w) can be 
normalized via b(w): C(w) = c(w)/b(w). The normalized LZC, 
C(w), reflects the rate at which new patterns occur along with 
the sequence. 
Data reduction 
LZC values were obtained for each of the 148 channels for 
each participant. Hence, 148 LZC scores per subject were 
submitted to statistical analyses. In order to avoid the statis-
tical problem of multiple comparisons, these 148 scores were 
grouped into five regions (see Figure 1) as performed previ-
ously: Anterior, Central, Left Lateral, Right Lateral, and 
Posterior (Fernandez et al., 2009, 2010) and the average 
LZC score across all channels within a region was used in 
all subsequent analyses. 
Statistical analyses 
We examined the differences between groups' means and stan-
dard deviations for statistical significance with a one-way anal-
ysis of variance (ANOVA) with a covariate. The relationship 
between LZC scores and age was determined using linear 
regression models. A Spearman Rho's correlation coefficient 
was utilized to examine the relationship between age and 
changes in HAMD scores. Finally, we fitted a logistic regres-
sion model to evaluate the contribution of LZC variables and 
age to the explanation of depression versus control group dif-
ferences. A Receiver Operating Characteristic (ROC) curve 
was used to evaluate the precision of the final model. 
Results 
Age and sex effects 
We first studied the effect of age and sex on LZC scores. 
Following our analysis design, we found that in the depressed 
group, neither Sex (all ^-values were >0.438) nor Age (all 
p-values were >0.125) were correlated with LZC. 
In the control group, Sex had no effect (all ^-values 
were >0.271), but there was a strong association between 
Age and LZC values in all five regions (all ^-values were 
<0.008). Because the variable Sex had no effect on LZC 
values, both samples were grouped independently of it for 
further analysis, while Age was entered as a covariate. 
Differences in LZC variables between depression and con-
trol group were evaluated using a one-way ANOVA with one 
covariate (Age). Age showed a significant effect on all LZC 
variables (^-values < 0.003). Only the variables Anterior 
(p = 0.045) and Right (p = 0.035) were statistically different 
between the two groups. 
Following this, the relationship between Age and LZC was 
analysed with two linear regression models, one for each 
group. In both groups all regression coefficients were positive 
(see Table 1), indicating a tendency to increased LZC scores 
as a function of age. While in controls LZC values increased 
significantly as a function of age in all sensor groups (all p-
values < 0.007), this tendency was not significant within 
the depression group (all p-values >0.140). The last row in 
Table 1 shows the ^-values of the comparison of regression 
lines' slopes between controls and MDD patients. The signif-
icantly different slope values in the Anterior (p = 0.0491), 
Central 0 = 0.0501), Left 0 = 0.038) and Right (p= 0.038) 
regions supports the notion of a significant positive tendency 
in controls that patients did not show. 
Comparison of patients and controb 
The statistical tendency observed in Figure 2 indicates that 
LZC values were greater in the depression group when com-
pared with controls, and that this tendency was present in all 
brain regions. Furthermore, LZC scores were age dependent. 
Considering this tendency, we carried out a logistic regres-
sion model to understand the contribution of the five regional 
LZC variables (see above), and Age, to the differences 
between depression versus control group. Following the oper-
ation as suggested by Hosmer and Lemeshow (1989), the final 
model which optimizes its discriminating capability contained 
Age (coefficient = 1.763), Anterior LZC (coefficient = 15.641) 
and Age*Ln(Age) (coefficient = —0.370) variables. The statis-
tical relevance of the logarithmic term (Age*Ln (Age)) indi-
cates that Age exhibits a non-linear behaviour, thus 
explaining why both groups tend to show an intersection 
point at certain Age values when the increase in LZC scores 
in healthy controls reach an upper limit. 
Figure 1. Sensor space representation of the five regions submitted to statistical analyses: Anterior, Central, Left lateral, Right lateral and Posterior. 
The area under the ROC curve was 0.763 (p = 0.005). The 
fitted model shows that Anterior is the sensor group with the 
greatest predictive power for depression. 
Effects of antidepressant treatment 
HAMD scores for all patients were lower after treatment 
(mean 5.10 ±2.36; p = 0.000) indicating that patients 
improved considerably. There was no significant correlation 
between age and the pre-post decrease in HAMD score 
(¿> = 0.120, Spearman Rho's correlation coefficient 
(rho = -0.359). 
As described previously, LZC scores in the Anterior sensor 
group could discriminate between patients and controls at 
baseline. In order to discover whether this measure was also 
sensitive to clinical improvement, we computed a new vari-
able called 'Anterior-Dif, which represented the change in 
Anterior LZC scores before and after treatment. 
The mean value of Anterior-Dif variable was positive 
(0.00950 ±0.4100), indicating that LZC scores in the 
Anterior area generally decreased with treatment in MDD 
patients, bringing them into line with controls' baseline 
LZC scores (see Figure 3) but the pre-treatment versus 
post-treatment mean comparison was not statistically signif-
icant (p = 0.156). However, since Age was previously associ-
ated with LZC values, and younger patients showed a slightly 
better clinical outcome than older patients, we studied the 
role of the variable Age in the post-treatment reduction of 
LZC values within the MDD group. 
Taking into account the mean age of the sample (47.55 
years), we divided the MDD sample in two groups: younger 
(<47 years) and older (>47 years). As shown in Figure 4; we 
found a significant reduction (p = 0.048) of Anterior LZC 
values in younger patients; however, this was not observed 
in the older ones (p= 0.546). Interestingly, these results indi-
cate a parallel tendency between HAMD and LZC values. 
Table 1. Slope coefficients of regression lines for the five areas, p-values and correlation coefficients (r) in patients with major depressive disorder 
(MDD) and controls for tempel-Ziv Complexity (tZC) scores. The last row shows p-values of regression lines' slopes in controls and MDD patients 
Anterior Central Left lateral Right lateral Posterior 
MDD Group 
Control Group 
Slope test 
0.0006 
(r= 0.2081) 
p = 0.3785 
0.0024 
(r = 0.5974) 
p = 0.0069 
p = 0.0491 
0.0005 
(r= 0.1864) 
p = 0.4312 
0.0019 
(r= 0.6589) 
p = 0.0022 
p = 0.0501 
0.0009 
(r = 0.2929) 
p = 0.2101 
0.0027 
(r = 0.7220 
p = 0.0005 
p = 0.0389 
0.0010 
(r= 0.3423) 
p = 0.1396 
0.0028 
(r=0.7123) 
p = 0.0006 
p = 0.0380 
0.0010 
(r= 0.3035) 
p = 0.1932 
0.0020 
(r= 0.7164) 
p = 0.0006 
p = 0.1234 
0.78 
0.76 
0.74 
0.72 
0.70 
0.68 
0.66 
0.64 
0.62 
0.60 
0.58 
• Dep. pre-treat 
D Control 
Anterior Central Left lateral Right lateral Posterior 
Figure 2. Mean and Standard Deviation of Lempel-Ziv Complexity (LZC) variables, for control and major depressive disorder (MDD) groups. 
A greater reduction in LZC values in younger patients seems 
to be associated with a better clinical outcome according to 
the HAMD severity scale. 
Figure 5 displays the regression lines of the variables 
Anterior versus Age for MDD patients before treatment, 
MDD patients after treatment, and controls. The regression 
coefficient of Anterior LZC scores after treatment was posi-
tive and statistically significant (p = 0.008), which suggests 
that the most important effect of an effective pharmaco-
logical treatment in patients with MDD was to recover the 
'normal' tendency initially observed in controls, with greater 
complexity values as a function of age. Furthermore, in post-
treatment evaluation no statistically significant differences 
were found between the slopes (p = 0.2360) and intercepts 
(¿> = 0.1383) of regression lines in controls and patients. 
Discussion 
We found that neural complexity, as measured using MEG 
and quantified using the LZC, was abnormal in patients with 
depression. LZC scores increased linearly with age in control 
subjects but this tendency was not observed in patients with 
depression. 
Secondly, we found that LZC values were higher in 
depressive patients in the anterior brain regions when com-
pared with controls and this difference, combined with the 
Depression prs-Lrealment Depression pcsl-lreatment 
Figure 3. Average Lempel-Ziv Complexity (LZC) values in major depressive disorder (MDD) patients and control subjects for aLL channels, from Al to 
A148, displayed in a colour scale. A significant reduction of Anterior scores can be observed in the sensor space representation within the MDD group. 
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relationship in major depressive disorder (MDD) patients pre-treatment 
(Dep.pre-treat), MDD patients post-treatment (Dep.post-treat) and 
controls. 
effect of age, allowed the classification of patients and con-
trols in a logistic regression model. Finally, we found that 
after 6 months of treatment with 30 mg of mirtazapine, 
LZC values decreased in patients with depression, especially 
in the younger patients, bringing them close to the controls' 
LZC values. However, the main effect of mirtazapine was to 
recover the tendency observed in controls, where LZC values 
increased linearly with age. 
The linear association of complexity with age in healthy 
people has been observed in previous studies (Anokhin et al., 
1996; Fernandez et al., 2009) Anokhin et al. found increased 
EEG dimensional complexity (another measure of complex-
ity) with age and a regional heterogeneity in the increase of 
EEG dimensional complexity within the first two decades of 
life, suggesting faster maturational changes in the anterior 
areas of the brain (Anokhin et al., 1996). Their findings sug-
gest that an increase in the complexity of brain dynamics lasts 
throughout the whole life span. 
Our finding of higher LZC values in depressive patients in 
anterior brain regions mirrors Li et al.'s (2008) results using 
EEG to measure LZC in patients with schizophrenia and in 
patients with psychotic depression. Depressive patients 
showed higher LZC values in most electrode sites compared 
with controls (Li et al., 2008). Also, Thomasson et al. (2000) 
observed that averaged global entropy (an estimate of EEG/ 
MEG complexity) slightly decreased during treatment in 
patients with depression (Thomasson et al., 2000). 
How can we explain this increased complexity of neural 
activity in patients with depression? EEG/MEG neural com-
plexity is closely related to the integrity of inter-neuronal 
connectivity, and increases with the number of different oscil-
latory systems active at the same time (Tononi and Edelman, 
1998). 
Using other methods, several authors have described 
increased functional connectivity in depression. Greicius 
et al. (2007) described increased functional connectivity 
using fMRI in depressive patients between subgenual anterior 
cingulate cortex, thalamus, orbitofrontal cortex, and precu-
neus (Greicius et al., 2007). Fingelkurts et al. described 
'strengthened' functional connectivity, mainly between short 
distance areas, using EEG structural synchrony in depressive 
patients during a resting condition (Fingelkurts et al., 2007). 
Increased functional connectivity might partially explain the 
elevated LZC values observed in patients with MDD, but as 
described in the introductory section, the key factor to explain 
higher complexity scores is increased frequency variability. 
Is increased frequency variability seen in MDD? In their 
excellent study, Fingelkurts et al. examined the composition 
of EEG brain oscillations in unmedicated MDD patients 
(Fingelkurts et al., 2006). They demonstrated that the EEG 
of depressed patients was characterized by more segments of 
polyrhythmic/disorganized activity as compared with con-
trols, and interpreted such disorganized activity as a sign of 
brain pathology. 
Finally, we observed that after 6 months of treatment with 
mirtazapine, LZC values decreased in patients with depres-
sion (especially within the younger patients), thus bringing 
LZC scores closer to those observed in controls. This could 
be considered one of the critical findings of our study. 
Our results indicate that clinical improvement, as revealed 
by a significant reduction in HAMD scores after 6 months of 
treatment with mirtazapine, is correlated with a decrease in 
complexity values which was significant in the group of 
patients younger than 47 years old. Marie-Mitchell et al. 
(2004) identified age as a non-specific predictor of treatment 
outcome in depression with both drug (fluoxetine or venlafax-
ine) and placebo treatment (Marie-Mitchell et al., 2004). 
Our study was limited by a relatively small sample size. 
This limitation might particularly affect pre-treatment versus 
post-treatment statistical comparisons, hence preventing the 
tendency of lower post-treatment LZC scores to reach statis-
tical significance. When we included the Age variable in the 
statistical model (either using linear regression or when the 
MDD sample was divided in two groups according to age) 
the reduction of post-treatment LZC scores emerged as a sig-
nificant effect. 
Also, because all of the patients in this study were treated 
with the same regimen of pharmacotherapy, it is not possible 
to determine whether the changes seen on the EEG after 6 
months of treatment were specifically related to the drug 
treatment (mirtazapine 30 mg), or whether they are related 
more broadly to the clinical improvement which may have 
been driven by other factors such as the placebo effect and 
the passage of time. 
Nevertheless, we conclude that complexity analysis of neural 
activity is a sensitive measure of detecting abnormal brain activ-
ity in clinical depression and may offer a potential approach 
in the evaluation of clinical improvement with treatment. 
To the best of our knowledge this is the first study to evaluate 
LZC after antidepressant treatment using EEG or MEG. 
Future studies should aim to replicate and build on these 
results. Also, we suggest that it would be necessary to evalu-
ate the effects of different treatment approaches such as psy-
chotherapy (i.e. cognitive behavioural therapy) and/or 
selective serotonin reuptake inhibitors, which are widely 
used as first line of treatment of depression in clinical practice. 
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